Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity-Reference-Cited by-同舟云学术

Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity

Published:2020-05-08 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Shen Shanling,Sckisel Gail,Sahoo Anupama,Lalani Almin,Otter Doug Den,Pearson Josh,DeVoss Jason,Cheng Jay,Casey Stephanie C.,Case Ryan,Yang Melissa,Low Ray,Daris Mark,Fan Bin,Agrawal Neeraj J.,Ali Khaled

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference52 articles.

1. The diverse functions of the PD1 inhibitory pathway.;Sharpe;Nat Rev Immunol.,2018

2. Inhibitors of the PD-1 pathway in tumor therapy.;LaFleur;J Immunol.,2018

3. Learning from PD-1 resistance: new combination strategies.;Bu;Trends Mol Med.,2016

4. Cancer immunotherapy using checkpoint blockade.;Ribas;Science.,2018

5. The future of immune checkpoint therapy.;Sharma;Science.,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD45 threads the needle of cytokine cancer immunotherapy;Nature Immunology;2024-09-09

2. Interleukin-4-Loaded Heparin Hydrogel Regulates Macrophage Polarization to Promote Osteogenic Differentiation;ACS Biomaterials Science & Engineering;2024-08-28

3. Advancements and challenges in immunocytokines: A new arsenal against cancer;Acta Pharmaceutica Sinica B;2024-08

4. Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview;Pharmaceutics;2024-07-24

5. Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy;Cancer Immunology Research;2024-06-24